COGNANO
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
240 Elm St Fl 2, Somerville, Massachuset...Website
www.cognano.co.jpRevenue
$43.8 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About COGNANO
COGNANO specializes in providing novel biomarkers essential for drug development decisions, utilizing antibody data and cutting-edge AI technology to create highly accurate drug candidates and diagnostic agents. The company aims to significantly enhance the speed of drug discovery by efficiently identifying treatment candidates based on extensive datasets, addressing unresolved medical challenges, and delivering new hope to patients. COGNANO has developed biomarkers for unmet medical needs, such as triple-negative breast cancer, and has published its findings in academic papers. Their innovative approach combines vast VHH data from alpacas and sharks with statistical methods and large language models to improve the success rates of drug development.Explore more
COGNANO Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is COGNANO your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on COGNANO recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at COGNANO
Check if COGNANO has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when COGNANO launches new products
Click to see if COGNANO had a recent Job posting/layoffs
COGNANO, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if COGNANO is spiking on competitors!
Funding: Get notified immidiatlly once COGNANO has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
COGNANO is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
COGNANO is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about COGNANO.
COGNANO Tech Stack
A closer look at the technologies used by COGNANO
COGNANO News & Media
A research paper from COGNANO with co-authors from Google on a large-scale dataset of antigen-antibody interactions was accepted by NeurIPS 2023
KYOTO, Japan--(BUSINESS WIRE)--Antibodies are the most important therapeutic modality in drug discovery because there is no substance that binds to target molecules (antigens) as precisely and strongly as antibodies. Living organisms can produce a huge variety of antibodies, derived from genes, in almost unlimited quantities - so much so that it is theoretically possible to search for effective antibodies based on huge collections of antibody-encoding genes in vivo. However, it is not easy to dCOGNANO, Inc.: Statistical Discovery of Triple-negative Breast Cancer-specific Antibodies From a Huge Database Obtained by Alpaca Immunization
KYOTO, Japan--(BUSINESS WIRE)--COGNANO, Inc. (Kyoto, Japan) and associates announced the discovery of a panel of antibodies specific for triple-negative breast cancer (TNBC). Breast cancer was the second leading cause of death for American women in 2022. To date, the three markers (Her2, ER and PgR) have been used for diagnosis that has increased life expectancy for many patients. However, patients with low expressions of these markers are diagnosed with TNBC and have the worst prognosis.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding COGNANO
Sign Up For FreeTo access detailed company insights
COGNANO specializes in providing novel biomarkers essential for drug development decisions, utilizing antibody data and cutting-edge AI technology to create highly accurate drug candidates and diagnostic agents. The company aims to significantly enhance the speed of drug discovery by efficiently identifying treatment candidates based on extensive d... Read More
